Tsuboi K - Search Results

1

Adoptive cell transfer therapy for malignant gliomas.

Ishikawa E, Takano S, Ohno T, Tsuboi K. Ishikawa E, et al. Among authors: tsuboi k. Adv Exp Med Biol. 2012;746:109-20. doi: 10.1007/978-1-4614-3146-6_9. Adv Exp Med Biol. 2012. PMID: 22639163 Review.

2

Effects of local injection of ex vivo expanded autologous tumor-specific T lymphocytes in cases with recurrent malignant gliomas.

Tsuboi K, Saijo K, Ishikawa E, Tsurushima H, Takano S, Morishita Y, Ohno T. Tsuboi K, et al. Clin Cancer Res. 2003 Aug 15;9(9):3294-302. Clin Cancer Res. 2003. PMID: 12960115

3

Autologous natural killer cell therapy for human recurrent malignant glioma.

Ishikawa E, Tsuboi K, Saijo K, Harada H, Takano S, Nose T, Ohno T. Ishikawa E, et al. Among authors: tsuboi k. Anticancer Res. 2004 May-Jun;24(3b):1861-71. Anticancer Res. 2004. PMID: 15274367 Free article. Clinical Trial.

4

X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions.

Ishikawa E, Tsuboi K, Saijo K, Takano S, Ohno T. Ishikawa E, et al. Among authors: tsuboi k. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1505-12. doi: 10.1016/j.ijrobp.2004.04.046. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275738

5

Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.

Harada H, Saijo K, Watanabe S, Tsuboi K, Nose T, Ishiwata I, Ohno T. Harada H, et al. Among authors: tsuboi k. Jpn J Cancer Res. 2002 Mar;93(3):313-9. doi: 10.1111/j.1349-7006.2002.tb02174.x. Jpn J Cancer Res. 2002. PMID: 11927014 Free PMC article.

6

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model.

Ishikawa E, Tsuboi K, Takano S, Uchimura E, Nose T, Ohno T. Ishikawa E, et al. Among authors: tsuboi k. Cancer Sci. 2004 Jan;95(1):98-103. doi: 10.1111/j.1349-7006.2004.tb03177.x. Cancer Sci. 2004. PMID: 14720334 Free PMC article.

7

Angiogenesis and antiangiogenic therapy for malignant gliomas.

Takano S, Kamiyama H, Tsuboi K, Matsumura A. Takano S, et al. Among authors: tsuboi k. Brain Tumor Pathol. 2004;21(2):69-73. doi: 10.1007/BF02484513. Brain Tumor Pathol. 2004. PMID: 15700836

8

Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.

Ishikawa E, Motohashi S, Ishikawa A, Ito T, Uchida T, Kaneko T, Tanaka Y, Horiguchi S, Okamoto Y, Fujisawa T, Tsuboi K, Taniguchi M, Matsumura A, Nakayama T. Ishikawa E, et al. Among authors: tsuboi k. Int J Cancer. 2005 Nov 1;117(2):265-73. doi: 10.1002/ijc.21197. Int J Cancer. 2005. PMID: 15900581

9

Anti-angiogenic and immunomodulatory effect of the herbal medicine "Juzen-taiho-to" on malignant glioma.

Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Kamiyama H, et al. Among authors: tsuboi k. Biol Pharm Bull. 2005 Nov;28(11):2111-6. doi: 10.1248/bpb.28.2111. Biol Pharm Bull. 2005. PMID: 16272699 Free article.

10

Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment.

Ishikawa E, Yamamoto T, Sakamoto N, Nakai K, Akutsu H, Tsuboi K, Takano S, Matsumura A. Ishikawa E, et al. Among authors: tsuboi k. Neurol Med Chir (Tokyo). 2010;50(8):638-44. doi: 10.2176/nmc.50.638. Neurol Med Chir (Tokyo). 2010. PMID: 20805645 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

875 results

Search Page

Filters